Elmiron (pentosan polysulfate sodium)
The CaseyGerry law firm is representing individuals who have developed pigmentary maculopathy as a result of taking the drug Elmiron.
Recently, studies have found a link between chronic exposure to Elmiron (pentosan polysulfate sodium) and pigmentary maculopathy, a disease that is unique to Elmiron exposure. Symptoms of pigmentary maculopathy include dim vision, difficulty reading, difficulty adjusting to the dark or low lighting and areas of vision loss. In some cases, vision loss is permanent.
If you have taken Elmiron and either have been diagnosed with pigmentary maculopathy or have experienced symptoms associated with maculopathy, you may be eligible for compensation. For a free consultation, please complete the Elmiron Litigation Questionnaire or call CaseyGerry at (619) 238-1811.